Replimune Group, Inc. — Director's Dealing 2021

Jul 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2021-07-15

Reporting Person: Love Colin (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-15	Common Stock	S	30000	$32.02	Disposed	835809	Direct

Footnotes

F1: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

F2: Following the sales reported on this Form 4, the reporting person continues to beneficially own 835,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 299,790 of which are exercisable as of the date hereof.